99 related articles for article (PubMed ID: 30738472)
1. [Establishment of Flow Cytometric Immunobead Array for Detecting Plasma Von Willebrand Factor Activity and Its Clinical Application in the Prognosis of Ischemic Stroke].
Yan B; He Y; Lu SQ; Xu MQ; Wang Q; Zhao YM; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):208-214. PubMed ID: 30738472
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel flow cytometric immunobead array to quantify VWF: Ag and VWF: GPIbR and its application in acute myocardial infarction.
Yan B; Xu M; Zhao Y; Guo H; Xia L; Ruan C; Zhao Y
Eur J Haematol; 2017 Sep; 99(3):207-215. PubMed ID: 28523822
[TBL] [Abstract][Full Text] [Related]
3. [Establishment and Clinical Application of Flow Cytometric Immunobead Array in Detecting Plasma von Willebrand Factor Antigen].
Yan B; He Y; Lu SQ; Qu L; Xu MQ; Wang Q; Zhao YM; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):235-241. PubMed ID: 32027283
[TBL] [Abstract][Full Text] [Related]
4. Plasma glycocalicin as a source of GPIbalpha in the von Willebrand factor ristocetin cofactor ELISA.
Vanhoorelbeke K; Pareyn I; Schlammadinger A; Vauterin S; Hoylaerts MF; Arnout J; Deckmyn H
Thromb Haemost; 2005 Jan; 93(1):165-71. PubMed ID: 15630508
[TBL] [Abstract][Full Text] [Related]
5. HemosIL VWF:GPIbR Assay Has a Greater Sensitivity than VWF:RCo Technique to Detect Acquired von Willebrand Syndrome in Myeloproliferative Neoplasms.
Laporte P; Tuffigo M; Ryman A; Fiore M; Rivière E; James C; Guy A
Thromb Haemost; 2022 Oct; 122(10):1673-1682. PubMed ID: 35322397
[TBL] [Abstract][Full Text] [Related]
6. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Egan B; Feeley TM; Coughlan T; Collins DR; O'Neill D; Murphy S; Lim SJ; Murphy RP; McCabe D
J Neurol Sci; 2017 Apr; 375():404-410. PubMed ID: 28320178
[TBL] [Abstract][Full Text] [Related]
7. Laboratory Testing for von Willebrand Factor Activity by Glycoprotein Ib Binding Assays (VWF:GPIb).
Patzke J; Favaloro EJ
Methods Mol Biol; 2017; 1646():453-460. PubMed ID: 28804847
[TBL] [Abstract][Full Text] [Related]
8. Comparison of an automated chemiluminescent assay to a manual ELISA assay for determination of von Willebrand Factor collagen binding activity on VWD plasma patients previously diagnosed through molecular analysis of VWF.
Jousselme E; Jourdy Y; Rugeri L; Négrier C; Nougier C
Int J Lab Hematol; 2018 Feb; 40(1):77-83. PubMed ID: 28980759
[TBL] [Abstract][Full Text] [Related]
9. Development of an ELISA method for testing VWF ristocetin cofactor activity with improved sensitivity and reliability in the diagnosis of von Willebrand disease.
Zhao Y; Gu Y; Ji S; Yang J; Yu Z; Ruan C
Eur J Haematol; 2012 May; 88(5):439-45. PubMed ID: 22268616
[TBL] [Abstract][Full Text] [Related]
10. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels.
Federici AB; Canciani MT; Forza I; Mannucci PM; Marchese P; Ware J; Ruggeri ZM
Haematologica; 2004 Jan; 89(1):77-85. PubMed ID: 14754609
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric immunobead assay for quantitative detection of platelet autoantibodies in immune thrombocytopenia patients.
Zhai J; Ding M; Yang T; Zuo B; Weng Z; Zhao Y; He J; Wu Q; Ruan C; He Y
J Transl Med; 2017 Oct; 15(1):214. PubMed ID: 29061180
[TBL] [Abstract][Full Text] [Related]
12. A comparative evaluation of a new fully automated assay for von Willebrand factor collagen binding activity to an established method.
Stufano F; Baronciani L; Mane-Padros D; Cozzi G; Faraudo S; Peyvandi F
Haemophilia; 2018 Jan; 24(1):156-161. PubMed ID: 29168270
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use.
Murdock PJ; Woodhams BJ; Matthews KB; Pasi KJ; Goodall AH
Thromb Haemost; 1997 Oct; 78(4):1272-7. PubMed ID: 9364997
[TBL] [Abstract][Full Text] [Related]
15. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.
Favaloro EJ; Mohammed S
Thromb Res; 2016 May; 141():202-11. PubMed ID: 26743192
[TBL] [Abstract][Full Text] [Related]
17. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
Aihara M; Kimura A; Chiba Y; Yoshida Y
Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
[TBL] [Abstract][Full Text] [Related]
18. Differential sensitivity of von Willebrand factor activity assays to reduced VWF molecular weight forms: A large international cross-laboratory study.
Favaloro EJ; Bonar R; Hollestelle MJ; Jennings I; Mohammed S; Meijer P; Woods T; Meiring M
Thromb Res; 2018 Jun; 166():96-105. PubMed ID: 29727738
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
[TBL] [Abstract][Full Text] [Related]
20. Expression and significance of vWF, GMP-140 and ADAMTS13 in patients with aneurysmal subarachnoid hemorrhage.
Li WH; Hui CJ; Ju H
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4350-4356. PubMed ID: 29077161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
